InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,539.37
(
0.52%
)
Post# of 252201
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

flatlander_60048

Send PM Follow Ignore
Followers 10
Posts 476
Boards Moderated 0
Alias Born 02/10/2006

flatlander_60048

Re: None

Monday, 09/19/2011 1:58:57 PM

Monday, September 19, 2011 1:58:57 PM

Post# of 252201
Got to admit feeling blindsided and that something is fishy. The FDA's response to Amphstar's lawsuit a few months ago made it seem that Amphstar's Lovenox candidate was wholly deficient in the majority of the evaluation criterion developed by the FDA. If this is true and the labeling concerns get worked out then you will probably see a rash of generic firms suing for approval.

I think there is another act to play out on this, flash crash rebound style.

FL
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up